// App-Quantinova.ai

TCT-290 : Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus: Results From the PIONEER III Clinical Trial

Researchers

Presenter

  • Alexander Thomas

Principal Investigators

  • Martin Leon

  • Andreas Baumbach

  • Stephan Windecker

  • Cody Pietras

  • Ovidiu Dressler

  • Melek Issever

  • Michael Curtis

  • Barry Bertolet

  • James Zidar

  • Pieter Smits

  • Victor Alfonso Jimenez Diaz

  • Brent McLaurin

  • Angel Cequier

  • Akihiko Takahashi

  • Giovanni Amoroso

  • Tsunekazu Kakuta

  • Robert Carney

  • Shigeru Saito

  • Alexandra Lansky

Medical Centers

  • Cardiovascular Research Foundation, New York, New York, USA

  • North Mississippi Medical Center, Tupelo, Mississippi, USA

  • Yale Cardiovascular Research Group, New Haven, Connecticut, USA

  • Bellvitge University Hospital, Barcelona, Spain

  • Swiss Cardiovascular Center Bern, Bern, Switzerland

  • Sakurakai Takahashi Hospital, Kobe, Japan

  • The Christ Hospital Health Network, Cincinnati, Ohio, USA

  • UNC/Rex Healthcare, Raleigh, North Carolina, USA

  • NewYork–Presbyterian/Columbia University Irving Medical Center, New York, New York, USA

  • Maasstad Ziekenhuis, Rotterdam, Netherlands

  • Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan

  • Yale School of Medicine, New Haven, Connecticut, USA

  • TSUCHIURA KYODO GENERAL HOSPITAL, Tsuchiura, Japan

  • Tyler Cardiovascular Consulatants, Tyler, Texas, USA

  • Yale University, New Haven, Connecticut, USA

  • Hospital Alvaro Cunqueiro, University Hospital of Vigo, Vigo, Spain

  • AnMed Health, Anderson, South Carolina, USA

  • OLVG, Amsterdam, the Netherlands

  • Foothills Medical Center, Calgary, Alberta, Canada

  • Barts Heart Centre, London, United Kingdom

Locations

  • United States

  • Japan

  • Spain

  • Switzerland

  • Netherlands

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved